Answers are grounded in this paper and cite their sources.
Although imaging is not mandatory in the initial workup of a patient with WM, a multimodality imaging approach can lead toward the diagnosis of a lymphoproliferative disorder, establish the tumor burden, identify sites of involvement, and thus explain the clinical presentation, help in determining prognosis and monitoring response to therapy, and help identify treatment-induced toxicity.
No takes yet. Share an insight, caveat, or question.
Thomas et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: